Hjem › Lungesygdomme › Tennessee
Lungesygdomme kliniske forsøg i Tennessee
15 studier for Lungesygdomme søger deltagere på steder i Tennessee.
Byer i Tennessee
Officiel studietekst (engelsk)
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
- SCRI Oncology Partners, Nashville
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT06765109A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- WR-Clinsearch, LLC, Chattanooga
RekruttererFase 3
Alder 12 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT06679140Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
- University of Tennessee Medical Center, Knoxville
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07489066A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- West Tennessee Research Institute, Jackson
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07013474American Lung Association (ALA) Lung Health Cohort
- Vanderbilt University Medical Center, Nashville
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 25 til 35 · Alle køn · Opdateret 23. sep. 2026 · NCT04543461Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Sarah Cannon Research Institue, Nashville
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT06128551A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Premier Research Center, LLC, Hendersonville
RekruttererFase 2
Alder 18 til 70 · Alle køn · Opdateret 22. sep. 2026 · NCT06977581A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Tennessee Oncology Chattanooga, Chattanooga
- University of Tennessee Medical Center, Knoxville
- Baptist Memorial Hospital-Memphis, Memphis
- og 2 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT06119581Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- Vanderbilt University Medical Center, Nashville
RekruttererFase 2
Alder 40 og opefter · Alle køn · Opdateret 4. sep. 2026 · NCT07059091Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
- Clinical Trials Center of Middle Tennesee LLC, Franklin
RekruttererFase 3
Alder 40 og opefter · Alle køn · Opdateret 3. sep. 2026 · NCT07284602A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
- SCRI Oncology Partners, Nashville
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 1. sep. 2026 · NCT05967689Cooperative Assessment of Late Effects for SCD Curative Therapies
- Vanderbilt University Medical Center, Nashville
RekruttererObservationsstudie
Alder 4 til 65 · Alle køn · Opdateret 27. jul. 2026 · NCT05153967Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
- University of Tennessee Medical Center, Knoxville
- Baptist Cancer Center, Memphis
RekruttererFase 2
Alder 18 til 70 · Alle køn · Opdateret 26. jun. 2026 · NCT04614103A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Baptist Memorial Hospital Baptist Cancer Center, Memphis
RekruttererFase 1/2
Alder 12 og opefter · Alle køn · Opdateret 27. maj 2026 · NCT03093116A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Tristar Bone Marrow Transplant, Nashville
- Vanderbilt-Ingram Cancer Center, Nashville
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 15. dec. 2025 · NCT06619561Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.